REQUEST A DEMO
Total
USD $0.00
Search more companies

Grownbury Pharmaceuticals Private Limited (India)

Main Activities: Basic Chemical Manufacturing
Full name: Grownbury Pharmaceuticals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Grownbury Pharmaceuticals Private Limited is an unlisted company, incorporated on 18/12/2009. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24100DL2009PTC197118 and registration number is 197118. The company is a trade company, it is engaged in retail trading.

Legal Address
28, New Layal Pur Extn. Krishna Nagar
Shahdara; Delhi; Postal Code: 110051

Contact Details: Purchase the Grownbury Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Grownbury Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Grownbury Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
December 18, 2009
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
91.84%
Purchase this report to view the information.
8.16%
Company Performance
Financial values in the chart are available after Grownbury Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
22.32%
Total operating revenue
22.38%
Operating profit (EBIT)
34.6%
EBITDA
33.86%
Net Profit (Loss) for the Period
30.18%
Total assets
-23.09%
Total equity
32.5%
Operating Profit Margin (ROS)
0.18%
Net Profit Margin
0.09%
Return on Equity (ROE)
-0.44%
Debt to Equity Ratio
-106.02%
Quick Ratio
-0.15%
Cash Ratio
-0.19%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?